T1	Participants 545 575	experimentally infected humans
T2	Participants 55 83	experimental human influenza
T3	Participants 710 747	2 large US university medical schools
T4	Participants 773 918	117 healthy adult volunteers (aged 18-40 years; median age, 21 years) who were susceptible (hemagglutination-inhibition antibody titer < or =1:8)
